IL32 and cancer: Collectively, miRNA regulation of the expression of interleukins (IL-11, IL-1β, IL-24 and IL-32) emerges as a useful tool in probing modulatory mechanisms of cancer promotion/suppression and their (in)direct implication in immunotherapeutic approaches.